Dr. Reddy’s Laboratories said that the Drugs Controller General of India (DCGI) has approved the single-shot Sputnik Light vaccine for restricted use in emergency situation in the country for protection against Covid-19.

Sputnik Light, which is a one-dose vaccine, is the same as the first component of the two-dose Sputnik V vaccine, which contains recombinant human adenovirus serotype number 26 (rAd26).

After a phase 3 clinical trial of the single-shot Sputnik Light vaccine in India, Dr. Reddy’s Laboratories sought approval for it from the DCGI in December 2021. The application filed by the Indian pharma company was on top of the data from a clinical trial held in Russia.

Sputnik Light is the second Covid-19 vaccine to be made available in India by Dr. Reddy’s Laboratories after the Sputnik V vaccine.

  COVID-19, DCGI, Dr. Reddy’s Laboratories, Drugs Controller General of India, India, Sputnik Light vaccine, Sputnik V vaccine